Remove tag long-term-plan
article thumbnail

A history of Pfizer

pharmaphorum

Few companies embody the term ‘pharma giant’ as much as Pfizer. The deal seemed to be a precursor to Pfizer’s plans to separate its patent-protected medicines business from its off-patent portfolio. The Board is firm in its conviction as to the appropriate terms to recommend to shareholders.”.

article thumbnail

Pharmaceutical Procurement Strategies Overview

Viseven

Outlining contract terms. The lack of supply chain transparency The lack of supply chain visibility makes it excruciatingly challenging for pharma companies to plan medicine production, forecast demand, and manage their inventory. Climate change is another factor, potentially disrupting supplies and contributing to hefty price tags.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Osteopathic Medicine and Surviving Your Second Year of Medical School with Dr. Bryce Brohol ?

The Physician Pharmacist

So, you know, was going to medical school, then always like your plan, it seems like you were focused more on pharmacy for that, you know, initial period of time. And just to clarify for the audience, you know, when it comes to medical school applications, most most of you might not be aware that it's actually a year long process.

article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

Bariatric surgeries show 30% weight loss in the first year and 25% weight loss in the long term,” says Papamargaritis, while that the clinical data for Mounjaro shows that the drug leads to a 16–22.5% To overcome manufacturing issues, in December 2021, Novo Nordisk announced its plans to build three new manufacturing facilities.

article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

Bariatric surgeries show 30% weight loss in the first year and 25% weight loss in the long term,” says Papamargaritis, while that the clinical data for Mounjaro shows that the drug leads to a 16–22.5% To overcome manufacturing issues, in December 2021, Novo Nordisk announced its plans to build three new manufacturing facilities.

article thumbnail

Ep. 005 – Dave Chase Podcast Transcript

Pharma Marketing Network

Dave (HR): Yeah, I mean really everything we’re doing you know is about overturning the devastating effects of the status quo health plans. I mean probably the only real exception is in specialty pharma in terms of, underlying cost actually having gone up. At best, it masks short-term pain while the underlying problem exists.